0.35 (0.77%) 1d
Their gene-editing biotechnology has lots of promise, but it's too early to tell, speculative. Buying this is a lottery ticket.

It’s a Buzzing Stocks opinion which is available only for Premium members

It's the review of the most popular stocks on social media. It's posted weekly to give you another view on the trending stocks, so you will not waste your precious time on scrolling social media feeds.

Biopharmaceutical company building gene editing based medicines for serious diseases. Riskier play, but gene editing would be a massive breakthrough and they have been the leaders in that space for a while. New to the trending stocks with 13 mentions in the past 24 hours.
A great spec. It's a genetic engineering company so it's bought on spec, not earnings.
A small company that develops transformative gene medications. They are a small fish in a big sea. A recent transaction with a pharma company allows them to scale out their product, but it is still early. (Analysts’ price target is $58.05)
They produce a gene-editing tool that splices DNA that has the potential of curing diseases such as Huntington's Chorea and cancer. It's new technology, but he can't think of another company doing this. This segment is very rich and a trading opportunity at best.
Showing 1 to 5 of 5 entries
  • «
  • 1
  • »

CRISPR Therapeutics AG(CRSP-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for CRISPR Therapeutics AG is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

CRISPR Therapeutics AG(CRSP-Q) Frequently Asked Questions

What is CRISPR Therapeutics AG stock symbol?

CRISPR Therapeutics AG is a American stock, trading under the symbol CRSP-Q on the NASDAQ (CRSP). It is usually referred to as NASDAQ:CRSP or CRSP-Q

Is CRISPR Therapeutics AG a buy or a sell?

In the last year, there was no coverage of CRISPR Therapeutics AG published on Stockchase.

Is CRISPR Therapeutics AG a good investment or a top pick?

CRISPR Therapeutics AG was recommended as a Top Pick by on . Read the latest stock experts ratings for CRISPR Therapeutics AG.

Why is CRISPR Therapeutics AG stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is CRISPR Therapeutics AG worth watching?

0 stock analysts on Stockchase covered CRISPR Therapeutics AG In the last year. It is a trending stock that is worth watching.

What is CRISPR Therapeutics AG stock price?

On 2023-09-29, CRISPR Therapeutics AG (CRSP-Q) stock closed at a price of $45.39.